Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND).
BACKGROUND: The objective of this research was to develop a disease-specific measure for fatigue in patients with motor neurone disease (MND) by generating data that would fit the Rasch measurement model. Fatigue was defined as reversible motor weakness and whole-body tiredness that was predominant...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2011
|
| _version_ | 1797065493980381184 |
|---|---|
| author | Gibbons, C Mills, R Thornton, E Ealing, J Mitchell, J Shaw, P Talbot, K Tennant, A Young, C |
| author_facet | Gibbons, C Mills, R Thornton, E Ealing, J Mitchell, J Shaw, P Talbot, K Tennant, A Young, C |
| author_sort | Gibbons, C |
| collection | OXFORD |
| description | BACKGROUND: The objective of this research was to develop a disease-specific measure for fatigue in patients with motor neurone disease (MND) by generating data that would fit the Rasch measurement model. Fatigue was defined as reversible motor weakness and whole-body tiredness that was predominantly brought on by muscular exertion and was partially relieved by rest. METHODS: Qualitative interviews were undertaken to confirm the suitability of a previously identified set of 52 neurological fatigue items as relevant to patients with MND. Patients were recruited from five U.K. MND clinics. Questionnaires were administered during clinic or by post. A sub-sample of patients completed the questionnaire again after 2-4 weeks to assess test-retest validity. Exploratory factor analyses and Rasch analysis were conducted on the item set. RESULTS: Qualitative interviews with ten MND patients confirmed the suitability of 52 previously identified neurological fatigue items as relevant to patients with MND. 298 patients consented to completing the initial questionnaire including this item set, with an additional 78 patients completing the questionnaire a second time after 4-6 weeks. Exploratory Factor Analysis identified five potential subscales that could be conceptualised as representing: 'Energy', 'Reversible muscular weakness' (shortened to 'Weakness'), 'Concentration', 'Effects of heat' and 'Rest'. Of the original five factors, two factors 'Energy' and 'Weakness' met the expectations of the Rasch model. A higher order fatigue summary scale, consisting of items from the 'Energy' and 'Weakness' subscales, was found to fit the Rasch model and have acceptable unidimensionality. The two scales and the higher order summary scale were shown to fulfil model expectations, including assumptions of unidimensionality, local independency and an absence of differential item functioning. CONCLUSIONS: The Neurological Fatigue Index for MND (NFI-MND) is a simple, easy-to-administer fatigue scale. It consists of an 8-item fatigue summary scale in addition to separate scales for measuring fatigue experienced as reversible muscular weakness and fatigue expressed as feelings of low energy and whole body tiredness. The underlying two factor structure supports the patient concept of fatigue derived from qualitative interviews in this population. All three scales were shown to be reliable and capable of interval level measurement. |
| first_indexed | 2024-03-06T21:29:24Z |
| format | Journal article |
| id | oxford-uuid:4428a984-66f3-4beb-96b0-8af612a830cd |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:29:24Z |
| publishDate | 2011 |
| record_format | dspace |
| spelling | oxford-uuid:4428a984-66f3-4beb-96b0-8af612a830cd2022-03-26T14:59:53ZDevelopment of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND).Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4428a984-66f3-4beb-96b0-8af612a830cdEnglishSymplectic Elements at Oxford2011Gibbons, CMills, RThornton, EEaling, JMitchell, JShaw, PTalbot, KTennant, AYoung, C BACKGROUND: The objective of this research was to develop a disease-specific measure for fatigue in patients with motor neurone disease (MND) by generating data that would fit the Rasch measurement model. Fatigue was defined as reversible motor weakness and whole-body tiredness that was predominantly brought on by muscular exertion and was partially relieved by rest. METHODS: Qualitative interviews were undertaken to confirm the suitability of a previously identified set of 52 neurological fatigue items as relevant to patients with MND. Patients were recruited from five U.K. MND clinics. Questionnaires were administered during clinic or by post. A sub-sample of patients completed the questionnaire again after 2-4 weeks to assess test-retest validity. Exploratory factor analyses and Rasch analysis were conducted on the item set. RESULTS: Qualitative interviews with ten MND patients confirmed the suitability of 52 previously identified neurological fatigue items as relevant to patients with MND. 298 patients consented to completing the initial questionnaire including this item set, with an additional 78 patients completing the questionnaire a second time after 4-6 weeks. Exploratory Factor Analysis identified five potential subscales that could be conceptualised as representing: 'Energy', 'Reversible muscular weakness' (shortened to 'Weakness'), 'Concentration', 'Effects of heat' and 'Rest'. Of the original five factors, two factors 'Energy' and 'Weakness' met the expectations of the Rasch model. A higher order fatigue summary scale, consisting of items from the 'Energy' and 'Weakness' subscales, was found to fit the Rasch model and have acceptable unidimensionality. The two scales and the higher order summary scale were shown to fulfil model expectations, including assumptions of unidimensionality, local independency and an absence of differential item functioning. CONCLUSIONS: The Neurological Fatigue Index for MND (NFI-MND) is a simple, easy-to-administer fatigue scale. It consists of an 8-item fatigue summary scale in addition to separate scales for measuring fatigue experienced as reversible muscular weakness and fatigue expressed as feelings of low energy and whole body tiredness. The underlying two factor structure supports the patient concept of fatigue derived from qualitative interviews in this population. All three scales were shown to be reliable and capable of interval level measurement. |
| spellingShingle | Gibbons, C Mills, R Thornton, E Ealing, J Mitchell, J Shaw, P Talbot, K Tennant, A Young, C Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND). |
| title | Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND). |
| title_full | Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND). |
| title_fullStr | Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND). |
| title_full_unstemmed | Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND). |
| title_short | Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND). |
| title_sort | development of a patient reported outcome measure for fatigue in motor neurone disease the neurological fatigue index nfi mnd |
| work_keys_str_mv | AT gibbonsc developmentofapatientreportedoutcomemeasureforfatigueinmotorneuronediseasetheneurologicalfatigueindexnfimnd AT millsr developmentofapatientreportedoutcomemeasureforfatigueinmotorneuronediseasetheneurologicalfatigueindexnfimnd AT thorntone developmentofapatientreportedoutcomemeasureforfatigueinmotorneuronediseasetheneurologicalfatigueindexnfimnd AT ealingj developmentofapatientreportedoutcomemeasureforfatigueinmotorneuronediseasetheneurologicalfatigueindexnfimnd AT mitchellj developmentofapatientreportedoutcomemeasureforfatigueinmotorneuronediseasetheneurologicalfatigueindexnfimnd AT shawp developmentofapatientreportedoutcomemeasureforfatigueinmotorneuronediseasetheneurologicalfatigueindexnfimnd AT talbotk developmentofapatientreportedoutcomemeasureforfatigueinmotorneuronediseasetheneurologicalfatigueindexnfimnd AT tennanta developmentofapatientreportedoutcomemeasureforfatigueinmotorneuronediseasetheneurologicalfatigueindexnfimnd AT youngc developmentofapatientreportedoutcomemeasureforfatigueinmotorneuronediseasetheneurologicalfatigueindexnfimnd |